Interview with Louis Chiang, President, Giddi Pharma Co. Ltd.
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi? When I founded this…
Address: Avenue Provinciale, 30
1340 Louvain-la-Neuve
Belgium
Tel: +32 (0)10 61 44 44
Web: http://www.iddi.com/
IDDI’s business is that of a eClinical and Biostatistical services provider for clinical trials since 1991. IDDI’s mission is to optimize the clinical development of drugs, biologics and devices, using a unique combination of advanced biostatistics and innovative data management technology.
Services:
Innovative trial design
Biostatistics: expert statistical analyses, validation of biomarkers, support to IDMC
Cost effective Data management and Electronic Data Capture
Professional Medical writing
eClinical Suite
IWRS / IVRS : ID-net™, a centralized randomization system integrated with EDC.
ID-supply™ , a drug inventory and treatment allocation system.
ID-code™, a coding of medical terms system based onMedDRA® and WHO-DRUG dictionaries.TrialControl™, a secure eRoom portal to access to key trial data and documents.
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi? When I founded this…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously struggling biotech he…
Belgian healthcare performs strongly across most metrics and international comparisons, but – as elsewhere – there remains room for improvement in terms of integrating patient feedback and experience into the…
20-year Astellas veteran Mark Dekker – now back in his home country of the Netherlands and overseeing the Benelux cluster having primarily developed his career in emerging European markets –…
Marnix Denys of beMedTech – the Belgian association for the medical technology industry – outlines the agenda priorities for the organisation that he hopes will lead to a more value-driven…
RaDiOrg aims to support rare disease patients and patient organisations in Belgium, defend their interests, and raise awareness of what can be devastating and little-understood conditions. Director Eva Schoeters –…
The newly merged Port of Antwerp-Bruges is the world’s first GDP-compliant seaport. CCO Tom Hautekiet explains the significant role the Port is playing in global healthcare supply chains – leveraging…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels* is now looking to reshape the future of cancer care with the biotech he helped co-found…
Univercells is a group of companies founded a decade ago based around the concept of revolutionizing the availability of biologics around the world through making essential medicines affordable to all,…
GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance, the British multinational suffered the impact…
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has elected a new president and vice presidents who have set out a key priority for their term: a series of…
Vanja Hoeben oversees the Benelux cluster for South Africa-headquartered specialty and branded pharma firm Aspen. He describes the reorganisation that his organisation has undergone in the past few years, some…
Maria Fernanda Prado highlights some of the lessons drawn from her extensive experience in emerging markets which remain applicable in her current role as Janssen’s managing director for the Benelux…
See our Cookie Privacy Policy Here